| Placebo | Green tea | P-value |
---|---|---|---|
FAS analysis | N = 16 | N = 17 |  |
Total MMSE Score, LSM ± SE | 1.04 ± 0.80 | 0.42 ± 0.77 | 0.59 |
 LSM difference [95 % CI] | −0.61 [−2.97, 1.74] | ||
NPI-Q: Total symptom score, LSM ± SE | 0.56 ± 0.74 | 0.23 ± 0.74 | 0.76 |
 LSM difference [95 % CI] | −0.34 [−2.52, 1.85] | ||
NPI-Q: Total distress score, LSM ± SE | −0.02 ± 0.64 | −0.27 ± 0.64 | 0.79 |
 LSM difference [95 % CI] | −0.25 [−2.17, 1.67] | ||
Blood pressure | |||
 SBP (mmHg), LSM ± SE | −1.94 ± 4.88 | −4.06 ± 4.69 | 0.76 |
  LSM difference [95 % CI] | −2.12 [−16.46, 12.22] | ||
 DBP (mmHg), LSM ± SE | −1.15 ± 3.71 | −2.93 ± 3.57 | 0.74 |
  LSM difference [95 % CI] | −1.79 [−12.69, 9.12] | ||
Serum lipid levels | |||
 TC (mg/dL), LSM ± SE | 0.41 ± 5.72 | −10.23 ± 5.50 | 0.20 |
  LSM difference [95 % CI] | −10.64 [−27.46, 6.18] | ||
 HDL-C (mg/dL), LSM ± SE | 0.69 ± 1.75 | 0.57 ± 1.68 | 0.96 |
  LSM difference [95 % CI] | −0.12 [−5.26, 5.02] | ||
 LDL-C (mg/dL), LSM ± SE | −4.26 ± 4.92 | −14.90 ± 4.73 | 0.14 |
  LSM difference [95 % CI] | −10.63 [−25.09, 3.83] | ||
 TG (mg/dL), LSM ± SE | −8.80 ± 11.59 | −1.32 ± 11.15 | 0.65 |
  LSM difference [95 % CI] | 7.48 [−26.60, 41.57] | ||
 MDA-LDL (U/L), LSM ± SE | 21.52 ± 7.21 | −1.41 ± 6.93 | 0.04 |
  LSM difference [95 % CI] | −22.93 [−44.13, −1.73] | ||
Blood glucose levels | |||
 FPG (mg/dL), LSM ± SE | 0.75 ± 10.46 | 4.38 ± 10.06 | 0.81 |
  LSM difference [95 % CI] | 3.63 [−27.13, 34.38] | ||
 HbA1c (%), LSM ± SE | 0.16 ± 0.08 | 0.01 ± 0.07 | 0.16 |
  LSM difference [95 % CI] | −0.16 [−0.38, 0.07] |